DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release Price, Uses, Alternatives, Dose, and more in UAE 2023
DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release
Drug name DEXILANT 60mg
Active substance Dexlansoprazole
Size : 14 s (7 s Blister x 2)
Type: Capsules (Hard Gelatin)/Modified Release
Company : TAKEDA PHARMACEUTICALS U.S.A., INC.
Uploaded By : Admin
ٍ Visits : 663 visit
What is Dexilant?
This drug belongs to the family of proton channel inhibitors, which work by blocking the production of gastric acid secreted by the gastric parietal cells, thus reducing acidity.
What are the uses of Dexilant?
Heartburn, caused by gastroesophageal reflux disease.
Erosive esophagitis (damage to the esophagus from stomach acid).
What are the contraindications to the use of Dexilant?
It is forbidden to use the medicine without consulting a specialist in the following cases:
Hypersensitivity to any of the components of the drug.
Children under 12 years old.
What are the side effects of Dexilant?
Nausea, vomiting, stomach pain, diarrhea.
Headache, mouth pain, sore throat, stuffy nose, sinus pain, or other symptoms of heartburn
What are the doses of Dexilant and methods of use?
The recommended dose for the treatment of esophageal prolapse: 60 mg per day for 8 weeks, and for the treatment of esophageal reflux: 30 mg per day for four weeks.
Welcome to Dwaey, specifically on DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release page.
This medicine contains an important and useful components, as it consists of Dexlansoprazole.
DEXILANT 60mg is available in the market in concentration 60mg/Capsule and in the form of Capsules (Hard Gelatin)/Modified Release.
TAKEDA PHARMACEUTICALS U.S.A., INC. is the producer of DEXILANT 60mg and it is imported from USA.
The most popular alternatives of DEXILANT 60mg are listed downward .
Lets know how to use DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release
Hepatic impairment. Gastric malignancy should be ruled out. Pregnancy and lactation. Lactation: Not known whether distributed into breast milk; discontinue nursing or drug
R-enantiomer of lansoprazole; PPI; binds to H+/K+-exchanging ATPase (proton pump) in gastric parietal cells, resulting in blockage of acid secretion.Dual release formulation.
Increased risk of hypomagnesaemia w/ diuretics and digoxin. May decrease plasma concentration of erlotinib, dasatinib and lapatinib. May decrease the bioavailability of itraconazole and ketoconazole. May increase plasma concentration of cilostazol and methotrexate. Reduced bioavailability w/ antacids and sucralfate. Potentially Fatal: May decrease serum levels and pharmacological effects of rilpivirine and atazanavir.